Global CRISPR gene editing market will reach $16,329.8 million by 2031, growing by 26.4% annually over 2021-2031, driven by the rising demand for better food and medical products, innovative advancement in gene therapy supported by the continued investments in healthcare, rising geriatric population and the increasing genomic and chronic diseases, and the development of rapid CRISPR-based POC tests amid COVID-19 pandemic.
Highlighted with 87 tables and 86 figures, this 180-page report “Global CRISPR Gene Editing Market 2021-2031 by Offering (Products, Services), Application (Biomedical, Agriculture, Industrial, Others), End User (Pharmaceutical Companies, Biotechnology Companies, Academic Institutions & Research Centers, Others), and Region: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire global CRISPR gene editing market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2018-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of global market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19. The balanced (most likely) projection is used to quantify global CRISPR gene editing market in every aspect of the classification from perspectives of Offering, Application, End User, and Region.
Based on Offering, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• CRISPR Products
o Kits & Enzymes
Vector-Based Cas9
DNA-Free Cas9
o Databases & Libraries
o Design Tools
o Antibodies
o CRISPR Plasmid & Vector
o Other Products
• CRISPR Services
o gRNA Design & Vector Construction
o Cell Line Engineering
o Microbial Gene Editing
o DNA Synthesis
o Other Services
Based on Application, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Biomedical Research & Therapy
o Gene Therapy
o Drug Discovery
o Diagnostics
o Other Biomedical Applications
• Agriculture
• Industrial Use
• Other Applications
By End User, the global market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Pharmaceutical Companies
• Biotechnology Companies
• Academic Institutions & Research Centers
• Other End Users
Geographically, the following regions together with the listed national/local markets are fully investigated:
• North America (U.S., Canada, and Mexico)
• Europe (Germany, UK, France, Spain, Italy, Netherlands, Rest of Europe; Rest of Europe is further segmented into Switzerland, Russia, Poland, Sweden, Belgium, Austria, Ireland, Norway, Denmark, and Finland)
• APAC (Japan, China, South Korea, Australia, India, and Rest of APAC; Rest of APAC is further segmented into Malaysia, Singapore, Indonesia, Thailand, New Zealand, Vietnam, Taiwan, and Philippines)
• South America (Brazil, Chile, Argentina, Rest of South America)
• MEA (UAE, Saudi Arabia, South Africa, Other Nations)
For each aforementioned region and country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of all regional markets by country and split of key national markets by Offering, Application, and End User, over the forecast years are also included.
The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
Abcam, Inc.
Agilent Technologies, Inc.
Applied StemCell, Inc.
Caribou Biosciences, Inc.
Cellecta, Inc.
CRISPR Therapeutics AG
Editas Medicine, Inc.
GeneCopoeia, Inc.
GeneScript Biotech Corporation
Horizon Discovery Group PLC
Integrated DNA Technologies, Inc.
Intellia Therapeutics Inc.
Lonza Group Ltd.
Merck KGaA
New England Biolabs, Inc.
Origene Technologies, Inc.
Rockland Immunochemicals, Inc.
Synthego Corporation
System Biosciences LLC
Takara Bio, Inc.
Thermo Fisher Scientific, Inc.
ToolGen, Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 9
1.1 Industry Definition and Research Scope 9
1.1.1 Industry Definition 9
1.1.2 Research Scope 11
1.2 Research Methodology 14
1.2.1 Overview of Market Research Methodology 14
1.2.2 Market Assumption 15
1.2.3 Secondary Data 15
1.2.4 Primary Data 15
1.2.5 Data Filtration and Model Design 16
1.2.6 Market Size/Share Estimation 17
1.2.7 Research Limitations 18
1.3 Executive Summary 19
2 Market Overview and Dynamics 21
2.1 Market Size and Forecast 21
2.1.1 Impact of COVID-19 on World Economy 24
2.1.2 Impact of COVID-19 on the Market 26
2.2 Major Growth Drivers 28
2.3 Market Restraints and Challenges 37
2.4 Emerging Opportunities and Market Trends 40
2.5 Porter’s Fiver Forces Analysis 44
3 Segmentation of Global Market by Offering 48
3.1 Market Overview by Offering 48
3.2 CRISPR Products 50
3.2.1 Kits & Enzymes 52
3.2.2 Databases & Libraries 53
3.2.3 Design Tools 54
3.2.4 Antibodies 55
3.2.5 CRISPR Plasmid & Vector 56
3.2.6 Other Products 57
3.3 CRISPR Services 58
3.3.1 gRNA Design & Vector Construction 60
3.3.2 Cell Line Engineering 61
3.3.3 Microbial Gene Editing 62
3.3.4 DNA Synthesis 63
3.3.5 Other Services 64
4 Segmentation of Global Market by Application 65
4.1 Market Overview by Application 65
4.2 Biomedical Research & Therapy 67
4.2.1 Gene Therapy 69
4.2.2 Drug Discovery 70
4.2.3 Diagnostics 71
4.2.4 Other Biomedical Applications 72
4.3 Agriculture 73
4.4 Industrial Use 74
4.5 Other Applications 75
5 Segmentation of Global Market by End User 76
5.1 Market Overview by End User 76
5.2 Pharmaceutical Companies 78
5.3 Biotechnology Companies 79
5.4 Academic Institutions & Research Centers 80
5.5 Other End Users 81
6 Segmentation of Global Market by Region 82
6.1 Geographic Market Overview 2021-2031 82
6.2 North America Market 2021-2031 by Country 86
6.2.1 Overview of North America Market 86
6.2.2 U.S. 90
6.2.3 Canada 93
6.2.4 Mexico 95
6.3 European Market 2021-2031 by Country 97
6.3.1 Overview of European Market 97
6.3.2 Germany 101
6.3.3 U.K. 103
6.3.4 France 105
6.3.5 Spain 107
6.3.6 Italy 109
6.3.7 Netherlands 111
6.3.8 Rest of European Market 113
6.4 Asia-Pacific Market 2021-2031 by Country 115
6.4.1 Overview of Asia-Pacific Market 115
6.4.2 Japan 119
6.4.3 China 122
6.4.4 Australia 124
6.4.5 India 126
6.4.6 South Korea 128
6.4.7 Rest of APAC Region 130
6.5 South America Market 2021-2031 by Country 132
6.5.1 Argentina 135
6.5.2 Brazil 137
6.5.3 Chile 139
6.5.4 Rest of South America Market 141
6.6 MEA Market 2021-2031 by Country 142
6.6.1 UAE 145
6.6.2 Saudi Arabia 147
6.6.3 South Africa 149
6.6.4 Other National Markets 151
7 Competitive Landscape 152
7.1 Overview of Key Vendors 152
7.2 New Product Launch, Partnership, Investment, and M&A 156
7.3 Company Profiles 157
Abcam, Inc. 157
Agilent Technologies, Inc. 159
Applied StemCell, Inc. 160
Caribou Biosciences, Inc. 161
Cellecta, Inc. 162
CRISPR Therapeutics AG 163
Editas Medicine, Inc. 164
GeneCopoeia, Inc. 165
GeneScript Biotech Corporation 166
Horizon Discovery Group PLC 167
Integrated DNA Technologies, Inc. 168
Intellia Therapeutics Inc. 169
Lonza Group Ltd. 170
Merck KGaA 171
New England Biolabs, Inc. 172
Origene Technologies, Inc. 173
Rockland Immunochemicals, Inc. 174
Synthego Corporation 175
System Biosciences LLC 176
Takara Bio, Inc. 177
Thermo Fisher Scientific, Inc. 178
ToolGen, Inc. 179
RELATED REPORTS 180
List of Tables:
Table 1. Snapshot of Global CRISPR Gene Editing Market in Balanced Perspective, 2021-2031 20
Table 2. World Economic Outlook, 2021-2031 25
Table 3. Developing Roadmap of CRISPR Technology 29
Table 4. Private and Public Companies Investment in CRISPR Technology 30
Table 5. Comparison of CRISPR with Other Gene Editing Technologies 33
Table 6. World Health Spending by Region, $ bn, 2013-2020 36
Table 7. Main Product Trends and Market Opportunities in Global CRISPR Gene Editing Market 40
Table 8. Global CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 48
Table 9. Global CRISPR Gene Editing Market: CRISPR Products by Type, 2021-2031, $ mn 51
Table 10. Global CRISPR Gene Editing Market: Kits & Enzymes by Type, 2021-2031, $ mn 52
Table 11. Global CRISPR Gene Editing Market: CRISPR Services by Type, 2021-2031, $ mn 59
Table 12. Global CRISPR Gene Editing Market by Application, 2021-2031, $ mn 65
Table 13. Global CRISPR Gene Editing Market: Biomedical Research & Therapy by Type, 2021-2031, $ mn 68
Table 14. Global CRISPR Gene Editing Market by End User, 2021-2031, $ mn 76
Table 15. Global CRISPR Gene Editing Market by Region, 2021-2031, $ mn 83
Table 16. Leading National CRISPR Gene Editing Market, 2021 and 2031, $ mn 85
Table 17. North America CRISPR Gene Editing Market by Country, 2021-2031, $ mn 88
Table 18. U.S. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 92
Table 19. U.S. CRISPR Gene Editing Market by Application, 2021-2031, $ mn 92
Table 20. U.S. CRISPR Gene Editing Market by End User, 2021-2031, $ mn 92
Table 21. Canada CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 94
Table 22. Canada CRISPR Gene Editing Market by Application, 2021-2031, $ mn 94
Table 23. Canada CRISPR Gene Editing Market by End User, 2021-2031, $ mn 94
Table 24. Mexico CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 96
Table 25. Mexico CRISPR Gene Editing Market by Application, 2021-2031, $ mn 96
Table 26. Mexico CRISPR Gene Editing Market by End User, 2021-2031, $ mn 96
Table 27. Europe CRISPR Gene Editing Market by Country, 2021-2031, $ mn 100
Table 28. Germany CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 102
Table 29. Germany CRISPR Gene Editing Market by Application, 2021-2031, $ mn 102
Table 30. Germany CRISPR Gene Editing Market by End User, 2021-2031, $ mn 102
Table 31. U.K. CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 104
Table 32. U.K. CRISPR Gene Editing Market by Application, 2021-2031, $ mn 104
Table 33. U.K. CRISPR Gene Editing Market by End User, 2021-2031, $ mn 104
Table 34. France CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 106
Table 35. France CRISPR Gene Editing Market by Application, 2021-2031, $ mn 106
Table 36. France CRISPR Gene Editing Market by End User, 2021-2031, $ mn 106
Table 37. Spain CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 108
Table 38. Spain CRISPR Gene Editing Market by Application, 2021-2031, $ mn 108
Table 39. Spain CRISPR Gene Editing Market by End User, 2021-2031, $ mn 108
Table 40. Italy CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 110
Table 41. Italy CRISPR Gene Editing Market by Application, 2021-2031, $ mn 110
Table 42. Italy CRISPR Gene Editing Market by End User, 2021-2031, $ mn 110
Table 43. Netherlands CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 112
Table 44. Netherlands CRISPR Gene Editing Market by Application, 2021-2031, $ mn 112
Table 45. Netherlands CRISPR Gene Editing Market by End User, 2021-2031, $ mn 112
Table 46. CRISPR Gene Editing Market in Rest of Europe by Country, 2021-2031, $ mn 114
Table 47. APAC CRISPR Gene Editing Market by Country, 2021-2031, $ mn 117
Table 48. Japan CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 121
Table 49. Japan CRISPR Gene Editing Market by Application, 2021-2031, $ mn 121
Table 50. Japan CRISPR Gene Editing Market by End User, 2021-2031, $ mn 121
Table 51. China CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 123
Table 52. China CRISPR Gene Editing Market by Application, 2021-2031, $ mn 123
Table 53. China CRISPR Gene Editing Market by End User, 2021-2031, $ mn 123
Table 54. Australia CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 125
Table 55. Australia CRISPR Gene Editing Market by Application, 2021-2031, $ mn 125
Table 56. Australia CRISPR Gene Editing Market by End User, 2021-2031, $ mn 125
Table 57. India CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 127
Table 58. India CRISPR Gene Editing Market by Application, 2021-2031, $ mn 127
Table 59. India CRISPR Gene Editing Market by End User, 2021-2031, $ mn 127
Table 60. South Korea CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 129
Table 61. South Korea CRISPR Gene Editing Market by Application, 2021-2031, $ mn 129
Table 62. South Korea CRISPR Gene Editing Market by End User, 2021-2031, $ mn 129
Table 63. CRISPR Gene Editing Market in Rest of APAC by Country/Region, 2021-2031, $ mn 131
Table 64. South America CRISPR Gene Editing Market by Country, 2021-2031, $ mn 134
Table 65. Argentina CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 136
Table 66. Argentina CRISPR Gene Editing Market by Application, 2021-2031, $ mn 136
Table 67. Argentina CRISPR Gene Editing Market by End User, 2021-2031, $ mn 136
Table 68. Brazil CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 138
Table 69. Brazil CRISPR Gene Editing Market by Application, 2021-2031, $ mn 138
Table 70. Brazil CRISPR Gene Editing Market by End User, 2021-2031, $ mn 138
Table 71. Chile CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 140
Table 72. Chile CRISPR Gene Editing Market by Application, 2021-2031, $ mn 140
Table 73. Chile CRISPR Gene Editing Market by End User, 2021-2031, $ mn 140
Table 74. MEA CRISPR Gene Editing Market by Country, 2021-2031, $ mn 144
Table 75. UAE CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 146
Table 76. UAE CRISPR Gene Editing Market by Application, 2021-2031, $ mn 146
Table 77. UAE CRISPR Gene Editing Market by End User, 2021-2031, $ mn 146
Table 78. Saudi Arabia CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 148
Table 79. Saudi Arabia CRISPR Gene Editing Market by Application, 2021-2031, $ mn 148
Table 80. Saudi Arabia CRISPR Gene Editing Market by End User, 2021-2031, $ mn 148
Table 81. South Africa CRISPR Gene Editing Market by Offering, 2021-2031, $ mn 150
Table 82. South Africa CRISPR Gene Editing Market by Application, 2021-2031, $ mn 150
Table 83. South Africa CRISPR Gene Editing Market by End User, 2021-2031, $ mn 150
Table 84. Breakdown of World Market by Key Vendor, 2021, % 154
Table 85. Abcam, Inc.: Company Snapshot 157
Table 86. Abcam, Inc.: Business Segmentation 158
Table 87. Abcam, Inc.: Product Portfolio 158
